Pr Press Articles, Journals and News
Latest News
How superwinds help drive galactic development
Galactic superwinds – large outflows of gas created by a combination of supernova explosions and stellar winds – are closely connected to a galaxy’s earliest stages of development and evolution, including aspects like its size, shape, and even how many stars will eventually call it home.
SARS-CoV-2 antigen levels linked to patient outcomes
The analysis revealed a strong correlation between higher SARS-CoV-2 antigen levels and worse pulmonary function at the time of enrollment.
NIH study of tea drinkers in the UK suggests health benefits for black tea
The study involved 498,043 men and women between ages 40 and 69.
خبير من مايو كلينك يقدم نصائح لتقليل خطر الإصابة بالخَرَف
ُعتقد أن أكثر من 55 مليون شخصٍ حول العالم مصابون بالخَرَف، وفقًا لمنظمة الصحة العالمية. يقول رونالد بيترسون، دكتور الطب، طبيب الأعصاب، ومدير مركز أبحاث داء الزهايمر التابع لمايو كلينك، إنه لا يمكن منع الخَرَف، ولكن يمكن تقليل خطر الإصابة به.
妙佑医疗国际(Mayo Clinic)专家谈如何降低痴呆症患病风险
根据世界卫生组织的数据，全球有超过5500万人患有不同程度的痴呆症。Ronald Petersen（医学博士）认为，痴呆症虽然无法预防，但有办法降低患病风险。Petersen博士是一名神经科医生，兼任妙佑医疗国际阿尔茨海默氏症研究中心主任。
Experto de Mayo Clinic Healthcare explica cuando los problemas de deglucion se consideran mas que un accidente
Muchas personas experimentan la incomodad de que un alimento o bebida se vaya accidentalmente por el lugar equivocado durante la deglucion. Sin embargo, los problemas de deglucion a veces se vuelven cronicos y pueden ser la senal de una enfermedad que deberia tratarse.
Especialista da Mayo Clinic da dicas para reduzir o risco de demencia
Acredita-se que mais de 55 milhoes de pessoas em todo o mundo vivam com demencia, de acordo com a Organizacao Mundial da Saude. O Dr. Ronald Petersen, neurologista e diretor do Centro de Pesquisa da Doenca de Alzheimer da Mayo Clinic, diz que nao e possivel evitar a demencia, mas que e possivel reduzir o risco.
A new type of defibrillator met safety, effectiveness goals in global clinical study
A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and effectiveness goals for participants in a premarket global clinical study. The device effectively terminated acute and chronic life-threatening ventricular arrhythmias. The findings were presented during a late-breaking session at the European Society of Cardiology Congress and were simultaneously published in The New England Journal of Medicine.
